CN104474528A - Medicine used for drainage detoxification - Google Patents

Medicine used for drainage detoxification Download PDF

Info

Publication number
CN104474528A
CN104474528A CN201410803966.9A CN201410803966A CN104474528A CN 104474528 A CN104474528 A CN 104474528A CN 201410803966 A CN201410803966 A CN 201410803966A CN 104474528 A CN104474528 A CN 104474528A
Authority
CN
China
Prior art keywords
medicine
drain
toxin expelling
ibuprofen
mylabris
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410803966.9A
Other languages
Chinese (zh)
Other versions
CN104474528B (en
Inventor
黎秋萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Xinding Management Consulting Co.,Ltd.
Original Assignee
Foshan Shunde Baotong Metal Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foshan Shunde Baotong Metal Technology Co Ltd filed Critical Foshan Shunde Baotong Metal Technology Co Ltd
Priority to CN201410803966.9A priority Critical patent/CN104474528B/en
Priority to CN201610564142.XA priority patent/CN105999219A/en
Publication of CN104474528A publication Critical patent/CN104474528A/en
Application granted granted Critical
Publication of CN104474528B publication Critical patent/CN104474528B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a medicine used for drainage detoxification, and belongs to the technical field of traditional Chinese medicine processing. The medicine used for drainage detoxification is prepared from lyttavesicatoria, reduced glutathione, ibuprofen and honey, and has the beneficial functions of reducing toxicity of lyttavesicatoria, contributing to drainage detoxification, eliminating inflammation, abating fever, relieving pain and restoring wounds without leaving scars. The medicine can enable the skin to automatically drain various toxins in body and cures diseases quickly without the need of cutting the skin by a needle, a knifeorother tools.

Description

For the medicine of drain toxin expelling
Technical field:
The invention belongs to the processing technique field of Chinese herbal medicine, particularly relate to a kind of medicine for drain toxin expelling.
Background technology:
The Chinese medicine of motherland is of extensive knowledge and profound scholarship, the method that the traditional Chinese medical science is cured the disease and medicine have a lot of ingenious practical invaluable experience, the Mylabris commonly used as forefathers is equipped with Realgar, Mel is used for losing meat cited stream, the toxin of discharging in body, reach the object for the treatment of, but Mylabris, Realgar are all poisonous things, and both gatherings add its toxicity.Of the present invention is to alleviate Mylabris toxicity, is beneficial to again drain toxin expelling, the benign pharmaceutical of tool anti-inflammation and sterilization, analgesia of bringing down a fever, reparation wound preventing from scar.
Summary of the invention:
For the medicine of drain toxin expelling, adopt Mylabris, reduced glutathion, ibuprofen, Mel to make, have and alleviate Mylabris toxicity, be beneficial to drain toxin expelling, have again an excellent effect of anti-inflammation and sterilization, analgesia of bringing down a fever, reparation wound preventing from scar.Medicine of the present invention, without the need to other instrument such as pin or cutter cutting skin, can allow skin automatic jet discharge various toxin in body, cure disease quickly.
The technical measures that the present invention takes:
For the medicine of drain toxin expelling, it is characterized in that: take raw material by weight: Mylabris 4-10 part, reduced glutathion 1.5-3 part, ibuprofen 0.5-2 part, Mel use as required.
By Mylabris except decaptitating, foot, wing and impurity, dry sterilization, pulverize, add reduced glutathion and ibuprofen mixing, then add micro-Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.(ibuprofen be granular answer pulverize)
Compared with prior art, the present invention has following beneficial effect:
1, the medicine of the present invention's employing compared with prior art, can alleviate the toxicity of Mylabris, be beneficial to drain toxin expelling, have anti-inflammation and sterilization again, analgesia of bringing down a fever, and repairs the excellent effect of wound preventing from scar.
2, antidote reduced glutathion is biological preparation, has the effect of various metals toxin and Mylabris toxin in good releasing Mylabris body, also has the activity that check melanin generates enzyme, reduces the formation of dermal melanin.
3, medicine can the disease of drain toxin expelling treatment: heating inflammation purulence redness of various symptom, arthromyodynia abscess pain, skin, hydrarthrosis pain, water wet hydrops, phlegm-damp gathering pain, the coalescent cold type of pain of blood stasis, gout swelling, traumatic injury wound congestive edema, carbuncle pyogenic infections from tumour or sore etc.
4, this safety of medicine, novelty, practicality, simple, be easy to use, determined curative effect.
Detailed description of the invention:
For the medicine of drain toxin expelling, it is characterized in that: take raw material by weight: Mylabris 4-10 part, reduced glutathion 1.5-3 part, ibuprofen 0.5-2 part, Mel use as required.
By Mylabris except decaptitating, foot, wing and impurity, dry sterilization, pulverize, add reduced glutathion and ibuprofen mixing, then add micro-Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
Embodiment 1
For the medicine of drain toxin expelling, it is characterized in that: take raw material by weight: Mylabris 4 parts, reduced glutathion 1.5 parts, ibuprofen 0.5 part, Mel use as required.
By Mylabris except decaptitating, foot, wing and impurity, dry sterilization, pulverize, add reduced glutathion and ibuprofen mixing, then add micro-Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
Embodiment 2
For the medicine of drain toxin expelling, it is characterized in that: take raw material by weight: Mylabris 10 parts, reduced glutathion 3 parts, ibuprofen 2 parts, Mel use as required.
By Mylabris except decaptitating, foot, wing and impurity, dry sterilization, pulverize, add reduced glutathion and ibuprofen mixing, then add micro-Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
Embodiment 3
For the medicine of drain toxin expelling, it is characterized in that: take raw material by weight: Mylabris 5 parts, reduced glutathion 1.5 parts, ibuprofen 1 part, Mel use as required.
By Mylabris except decaptitating, foot, wing and impurity, dry sterilization, pulverize, add reduced glutathion and ibuprofen mixing, then add micro-Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
Using method: by affected part alcohol disinfecting, provokes trace drug with toothpick and to apply ointment or plaster affected part, about Semen phaseoli radiati size, a few place of strong opponent cloth-like multiple spot medicine as large in affected part area, applies trauma plaster at powder and fixes, raise after 6-8 hour, paste medicine place and namely see a blister, needle with sterile needle, can drain toxin expelling.After wound wound healing, as disease is not fully recovered, can drain toxin expelling again, take the circumstances into consideration the Chinese patent medicine with the use of dialling taking poison and growing muscle due simultaneously.
Note: avoid eat Semen arachidis hypogaeae, Semen Glycines, beef, Cyprinus carpio, decoct, explode, the food of pungent stimulation.
Said medicine does not enter that eye is fine, anemia of pregnant woman's forbidding
Wherein, the efficacy effect of each medicine, treatment disease is as follows:
Mylabris is pungent, warm, malicious greatly, returns liver, stomach, kidney channel.Counteracting toxic substances phagedenoma, removing blood stasis eliminating stagnation, cure mainly carbuncle, scrofula, stubborn dermatitis, amenorrhea, cancerous protuberance.Dead flesh can be lost, attack Fructus Myricae rubrae malignant boil, by blood reason pain." not Lu ": " main scabies, accumulation of blood, induced abortion." " property of medicine opinion ": " control scrofula, tonneau water channel.”
Reduced glutathion white crystals (general merchandise is pale yellow powder) is water-soluble, there are scavenging free radicals and antioxidative effect, there is the toxic action removing metal toxin and epoxide, energy check melanin generates the activity of enzyme, reduce melanic formation, improve skin oxidation resistance and make skin produce gloss.Also has liver-protective effect.
Ibuprofen has another name called Ibuprofen, ibuprofen, and this product is non-steroidal anti-inflammatory drugs, has analgesia and brings down a fever and antiinflammation.For rheumatism and rheumatoid arthritis, for pain, the pain alleviating gouty arthritis.
Mel is sweet, put down, return spleen, stomach, lung, large intestine channel, invigorating middle warmer, cough-relieving, moisturizes, detoxifies, and is used as removing toxic substances and effect that is sticky and medicine here.
Clinical practice:
Patient 24 people of traumatic injury wound congestive edema, 12 people are after 3 drain toxin expelling usings method, then at the relative medicine of affected part application therapy traumatic injury wound, 6 people's recoveries from illness, 4 people are clearly better, and 2 people are effective.12 people after 4 drain toxin expellings, then take the medicine for the treatment of traumatic injury wound, and 8 people's recoveries from illness, 3 people are clearly better, and 1 people is invalid.
Patient 37 people of rheumatism arthromyodynia, cold-damp arthromyodynia, gouty arthritis, after 8-9 drain toxin expelling method, then to apply ointment or plaster the medicine of corresponding treatment and edible medicine at affected part, 12 people's recoveries from illness, 16 people are clearly better, and 6 people are effective, and 3 people are invalid.

Claims (4)

1. for the medicine of drain toxin expelling, it is characterized in that: take raw material by weight: Mylabris 4-10 part, reduced glutathion 1.5-3 part, ibuprofen 0.5-2 part, Mel use as required,
By Mylabris except decaptitating, foot, wing and impurity, dry sterilization, pulverize, add reduced glutathion and ibuprofen mixing, then add micro-Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
2. want the medicine for drain toxin expelling described in 1 according to right, it is characterized in that: take raw material by weight: Mylabris 4 parts, reduced glutathion 1.5 parts, ibuprofen 0.5 part, Mel use as required,
By Mylabris except decaptitating, foot, wing and impurity, dry sterilization, pulverize, add reduced glutathion and ibuprofen mixing, then add micro-Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
3. according to claim 1 for the medicine of drain toxin expelling, it is characterized in that: take raw material by weight: Mylabris 10 parts, reduced glutathion 3 parts, ibuprofen 2 parts, Mel use as required,
By Mylabris except decaptitating, foot, wing and impurity, dry sterilization, pulverize, add reduced glutathion and ibuprofen mixing, then add micro-Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling.
4. according to claim 1 for the medicine of drain toxin expelling, it is characterized in that: take raw material by weight: Mylabris 5 parts, reduced glutathion 1.5 parts, ibuprofen 1 part, Mel use as required,
By Mylabris except decaptitating, foot, wing and impurity, dry sterilization, pulverize, add reduced glutathion and ibuprofen mixing, then add micro-Mel and fully mix into solid paste thoroughly, after packaging, become the medicine for drain toxin expelling;
Using method: by affected part alcohol disinfecting, provokes trace drug with toothpick and to apply ointment or plaster affected part, about Semen phaseoli radiati size, a few place of strong opponent cloth-like multiple spot medicine as large in affected part area, applies trauma plaster at powder and fixes, raise after 6-8 hour, paste medicine place and namely see a blister, needle with sterile needle, can drain toxin expelling.After wound wound healing, as disease is not fully recovered, can drain toxin expelling again, take the circumstances into consideration the Chinese patent medicine with the use of dialling taking poison and growing muscle due simultaneously.
CN201410803966.9A 2014-12-19 2014-12-19 Medicine for drainage toxin expelling Active CN104474528B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201410803966.9A CN104474528B (en) 2014-12-19 2014-12-19 Medicine for drainage toxin expelling
CN201610564142.XA CN105999219A (en) 2014-12-19 2014-12-19 Medicine for expelling noxious substances in drainage manner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410803966.9A CN104474528B (en) 2014-12-19 2014-12-19 Medicine for drainage toxin expelling

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201610564142.XA Division CN105999219A (en) 2014-12-19 2014-12-19 Medicine for expelling noxious substances in drainage manner

Publications (2)

Publication Number Publication Date
CN104474528A true CN104474528A (en) 2015-04-01
CN104474528B CN104474528B (en) 2016-09-07

Family

ID=52749229

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201610564142.XA Withdrawn CN105999219A (en) 2014-12-19 2014-12-19 Medicine for expelling noxious substances in drainage manner
CN201410803966.9A Active CN104474528B (en) 2014-12-19 2014-12-19 Medicine for drainage toxin expelling

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201610564142.XA Withdrawn CN105999219A (en) 2014-12-19 2014-12-19 Medicine for expelling noxious substances in drainage manner

Country Status (1)

Country Link
CN (2) CN105999219A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105126070A (en) * 2015-09-05 2015-12-09 佛山市顺德区宝铜金属科技有限公司 Medicine for external treatment of scrofula and thyroid tumor
CN105126069A (en) * 2015-09-05 2015-12-09 佛山市顺德区宝铜金属科技有限公司 Medicine for external treatment of scrofula and gall
CN105169365A (en) * 2015-09-05 2015-12-23 佛山市顺德区宝铜金属科技有限公司 Medicine for external treatment of scrofula and gall

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1083720A (en) * 1993-02-03 1994-03-16 金惠生 " Lingdan " moxibustion plaster
CN1083720C (en) * 1998-11-19 2002-05-01 潘建新 Chinese patent drug for curing cirrhosis and splenceratosis disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1083720A (en) * 1993-02-03 1994-03-16 金惠生 " Lingdan " moxibustion plaster
CN1083720C (en) * 1998-11-19 2002-05-01 潘建新 Chinese patent drug for curing cirrhosis and splenceratosis disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
胡成穆等: "非甾体抗炎药药物代谢酶多态性的研究进展", 《安徽医药》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105126070A (en) * 2015-09-05 2015-12-09 佛山市顺德区宝铜金属科技有限公司 Medicine for external treatment of scrofula and thyroid tumor
CN105126069A (en) * 2015-09-05 2015-12-09 佛山市顺德区宝铜金属科技有限公司 Medicine for external treatment of scrofula and gall
CN105169365A (en) * 2015-09-05 2015-12-23 佛山市顺德区宝铜金属科技有限公司 Medicine for external treatment of scrofula and gall

Also Published As

Publication number Publication date
CN104474528B (en) 2016-09-07
CN105999219A (en) 2016-10-12

Similar Documents

Publication Publication Date Title
CN103961636B (en) Orthopedic disease treatment external application traditional Chinese medicine composition, preparation method and application thereof
CN104474528A (en) Medicine used for drainage detoxification
CN104491220B (en) A kind of traditional Chinese medicine composition for herpes
CN103656092A (en) Ointment for treating trauma and preparation method thereof
CN105943666B (en) Composition for nursing sensitive skin of infant and preparation method thereof
CN102961510B (en) Vulnerary hemostatic and preparation technology thereof
CN101711807B (en) Antiphlogistic and antibiotic ointment
CN101780193A (en) Special-effect plaster for treating fractures and various non-healing wounds
CN111991471A (en) A topical Chinese medicinal preparation for treating knife wound, burn and scald, and its preparation method
CN104306562A (en) Ointment for treating blister type beriberi and preparing method thereof
CN101244138B (en) Externally used traditional Chinese medicine preparation for treating frostbite
CN103611007A (en) Ointment and preparation method thereof
CN103705779B (en) A kind of Chinese medicine composition treating contact dermatitis of face
CN101897874B (en) External healing Chinese medicinal ointment
CN102451249B (en) Drug for treating burn and scald, and application thereof
CN110227109B (en) Composition for chronic eczema of pigs and preparation method thereof
CN107050302A (en) Treat the external application Chinese medicine of burn and scald
CN107233406A (en) A kind of traditional Chinese medicine for outer use for treating hormone face
CN105816793A (en) Traditional Chinese medicine for treating various hyperplasia and cyst diseases and preparation method thereof
CN104383057A (en) Paste for mainly treating traumatic injury and preparation method of paste for mainly treating traumatic injury
CN104887702A (en) Chinese medicinal composition for treating skin injury and ulceration and preparation method thereof
CN104257931A (en) Orthopedic traumatic injury external application patch and preparation method thereof
CN104147315A (en) Emulsion medicine for treating scald and burn and preparation method thereof
CN103356965A (en) Drug for curing rheumatoid arthritis
CN103316321B (en) Colitis treatment spray

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Yu Li

Inventor after: Jiang Hua

Inventor after: Gu Huiqian

Inventor after: Li Zhongcheng

Inventor before: Li Qiuping

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20160812

Address after: 266109 10-4-101, 480 Hua Cheng Road, Chengyang District, Shandong, Qingdao

Applicant after: Li Zhongcheng

Address before: 528300 Guangdong Province, Foshan city Shunde District Daliang City Ring Road Fumin Building No. 505

Applicant before: FOSHAN CITY SHUNDE DISTRICT BAOTONG METAL TECHNOLOGY CO., LTD.

C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20211026

Address after: 257000 room 2007, employment and entrepreneurship center, No. 290, Nanyi Road, Dongying District, Dongying City, Shandong Province

Patentee after: Shandong Xinding Management Consulting Co.,Ltd.

Address before: 266109 10-4-101, No. 480, Huacheng Road, Chengyang District, Qingdao City, Shandong Province

Patentee before: Li Zhongcheng

TR01 Transfer of patent right